NEW: No-Cost StreetSmart Live! Events. This type of intellectual capital is usually not made available to the general public. Learn More

Cynata Therapeutics Ltd. is an Australian stem cell and regenerative medicine company that is developing Cymerus, a therapeutic stem cell platform technology that utilizes discoveries made at the University of Wisconsin-Madison (UWM). UWM is a world-renowned leader in stem cell research, in large part due to the work of Professor James Thomson and his group, which produced the first successful isolation of human embryonic stem cells in 1998 and the derivation of induced pluripotent stem cells (iPSCs) from human adult cells in 2007. Professor Igor Slukvin, a co-founder of Cynata, was also a member of the team that conducted UWM's pioneering iPSC research.